NCT04526886 2025-10-06
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Dartmouth-Hitchcock Medical Center
Phase NA Completed
Clinical Trials
8 trialsNCT07185893 2025-09-22
A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors
Hebei Medical University Fourth Hospital
Phase NA Not yet recruiting
NCT01660347 2025-05-02
Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant
Thomas Jefferson University
Phase NA Withdrawn
NCT05634005 2025-03-06
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
University of Utah
Phase NA Completed
NCT06455553 2025-02-13
VISCOTHEM-1
Centre Hospitalier Annecy Genevois
Phase NA Completed
NCT04609891 2022-04-29
Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors
Anhui Provincial Cancer Hospital
Phase NA Completed
NCT01615146 2015-09-02
OPTIMAL
Ottawa Hospital Research Institute
Phase NA Terminated
NCT00608738 2012-07-10
Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment
Northwestern University
Phase NA Completed